Mary Beth Westerman (@drmbwesterman) 's Twitter Profile
Mary Beth Westerman

@drmbwesterman

Assoc. Prof & PD @LSUUrology | co-director urologic oncology | @MDAndersonNews & @MayoUrology grad | Fascial sparing 🔪 l 0 day LOS l clinical trials

ID: 1050815222

calendar_today31-12-2012 17:34:23

866 Tweet

1,1K Takipçi

1,1K Takip Edilen

Mary Beth Westerman (@drmbwesterman) 's Twitter Profile Photo

Thanks to ECOG-ACRIN Cancer Research Group for opportunity to talk about our enrollment strategy for EA8212/BRIDGE LSU Department of Urology 👍🏻easy trial to operationalize, especially for NCORP sites Check out protocol on ctsu.org Reach out with ❓❓

Thanks to <a href="/eaonc/">ECOG-ACRIN Cancer Research Group</a> for opportunity to talk about our enrollment strategy for EA8212/BRIDGE <a href="/LSUUrology/">LSU Department of Urology</a> 

👍🏻easy trial to operationalize, especially for NCORP sites 

Check out protocol on ctsu.org 

Reach out with ❓❓
Eddie Cliff (@eddie_cliff) 's Twitter Profile Photo

Dutch oncologists revised their criteria: "In patients who cannot be cured & who are expected to live <1 year, treatment should actually prolong life, not just prolong the time at which the disease does not get worse on a CT scan." nvmo.org/2023/05/herzie… Bishal Gyawali Common Sense Oncology

Mary Beth Westerman (@drmbwesterman) 's Twitter Profile Photo

Congrats to my co-fellow Daniel Shapiro for his amazing work on renal medullary carcinoma MD Anderson Cancer Center Was a privilege to witness (and measure the occasional mouse tumor) A true surgeon- scientist - excited to see the RMC story unfold YUO R.M.C. Inc Chris Johnson Foundation Inc.

Brian F. Chapin (@chapinmd) 's Twitter Profile Photo

Alberto Bossi presenting PEACE-1 data on ADT+Abi +/-RTin M1 HSPCa. Improves rPFS and time to CRPC progression in LV No improvement in OS in LV. Lots of questions remain. Consider enrolling to S1802!

<a href="/AlbertoBossial/">Alberto Bossi</a>  presenting PEACE-1 data on ADT+Abi +/-RTin M1 HSPCa. 

Improves rPFS and time to CRPC progression in LV

No improvement in OS in LV. 

Lots of questions remain. Consider enrolling to S1802!
Tanya Dorff (@tdorffonc) 's Twitter Profile Photo

Intrigued by reduction in local symptoms with RT in PEACE-1. will be interesting to see how prostatectomy impacts this in #S1802 and of course whether OS could be improved with cytoreductive surgery though RT did not #ASCO23 - please support SWOG trial

Intrigued by reduction in local symptoms with RT in PEACE-1. will be interesting to see how prostatectomy impacts this in #S1802 and of course whether OS could be improved with cytoreductive surgery though RT did not #ASCO23 - please support SWOG trial
Max Kates (@maxkates) 's Twitter Profile Photo

Background and Update for ECOG-ACRIN EA8212: A Randomized Phase 3 Trial of Intravesical Bacillus Calmette-Guérin (BCG) Versus Intravesical Docetaxel and Gemcitabine Treatment in BCG-naïve High-grade Non–muscle-invasive Bladder Cancer (BRIDGE) sciencedirect.com/science/articl…

Scott Delacroix M.D. (@urocancer) 's Twitter Profile Photo

Bourbon Raffle for a good cause. Access to clinical trials for men with PCA LSU Department of Urology BSoBR Screw Cancer 2023 Raffle | Raffle Creator rafflecreator.com/pages/50530/bs… via Raffle Creator

Brian F. Chapin (@chapinmd) 's Twitter Profile Photo

The Univ. of Texas, Christopher G Wood Advances in Urologic Oncology Symposium April 12-14, 2024 Omni Barton Creek, Austin Great venue and amazing collaboration of programs Mark your calendars! #oncsurgery MD Anderson Cancer Center @UTSWNews UTMB Health University of Texas Houston Urology UT Austin UTSA

The Univ. of Texas, Christopher G Wood Advances in Urologic Oncology Symposium 

April 12-14, 2024
Omni Barton Creek, Austin 

Great venue and amazing collaboration of programs

Mark your calendars!
#oncsurgery <a href="/MDAndersonNews/">MD Anderson Cancer Center</a> @UTSWNews <a href="/utmbhealth/">UTMB Health</a> 
<a href="/UTHUrology/">University of Texas Houston Urology</a> <a href="/UTAustin/">UT Austin</a> <a href="/UTSA/">UTSA</a>
YUO (@suo_yuo) 's Twitter Profile Photo

Exciting times ahead! YUO is opening three positions for the upcoming year and seeking one fellow for the YUO Steering Committee. If you're within 7.5 years of your fellowship, you're eligible. 🚨 Application deadline: October 15th. More details below. Society of Urologic Oncology

Exciting times ahead! YUO is opening three positions for the upcoming year and seeking one fellow for the YUO Steering Committee. If you're within 7.5 years of your fellowship, you're eligible. 🚨 Application deadline: October 15th. More details below. <a href="/UroOnc/">Society of Urologic Oncology</a>
Mary Beth Westerman (@drmbwesterman) 's Twitter Profile Photo

Missed #ESMO23 ? The Society of Urologic Oncology Education Committee is hosting a webinar! Speakers: Bernadett Szabados - ABACUS-2 Zayd Tippu - Molecular Landscape of GU Onc Wenxin XU- LITESPARK Trials Oliver Sartor - PSMAfore 10/30/23 6pm CST us02web.zoom.us/meeting/regist…

Missed #ESMO23 ? The <a href="/UroOnc/">Society of Urologic Oncology</a> Education Committee is hosting a webinar!  

Speakers: 
Bernadett Szabados - ABACUS-2
Zayd Tippu - Molecular Landscape of GU Onc
Wenxin XU- LITESPARK Trials
Oliver Sartor - PSMAfore

10/30/23
6pm CST

us02web.zoom.us/meeting/regist…
Zach Klaassen (@zklaassen_md) 's Twitter Profile Photo

Impact of Rural Location on Receipt of SoC Rx and Survival for MIBC in Louisiana Ashley Foret Mary Beth Westerman #SESAUA24 UroToday.com 📌n=983, 85.6% lived in urban areas, 22.6% non-Hispanic Black, 37.5% SoC Rx 📌Urban vs rural: - mCSS: 58.7 mo vs 26.9 mo, p=0.0049 -mOS: 27.7 mo vs

Impact of Rural Location on Receipt of SoC Rx and Survival for MIBC in Louisiana <a href="/Ashley_Foret_/">Ashley Foret</a> <a href="/DrMBWesterman/">Mary Beth Westerman</a> #SESAUA24 <a href="/urotoday/">UroToday.com</a> 

📌n=983, 85.6% lived in urban areas, 22.6% non-Hispanic Black, 37.5% SoC Rx
📌Urban vs rural:
- mCSS: 58.7 mo vs 26.9 mo, p=0.0049
-mOS: 27.7 mo vs
Keith Kowalczyk, MD (@keithkow) 's Twitter Profile Photo

Enhance your robotic prostatectomy skills for superior patient outcomes! Join us at #AUA24 on Saturday, May 4th for an exclusive course on pelvic fascia sparing and beyond. Let’s share and evolve techniques together—because our patients deserve the best. 🤖⚕️John W. Davis, MD

Enhance your robotic prostatectomy skills for superior patient outcomes! Join us at #AUA24 on Saturday, May 4th for an exclusive course on pelvic fascia sparing and beyond. Let’s share and evolve techniques together—because our patients deserve the best. 🤖⚕️<a href="/jdhdavis/">John W. Davis, MD</a>
Scott Delacroix M.D. (@urocancer) 's Twitter Profile Photo

My 38 year old brother in law (with 2 kids under 10) is sitting in a great hospital Ochsner Health but is requiring transfer to UC San Diego Health for pulmonary artery endarterectomy. BCBS New Mexico is road blocking (taking forever to approve) the transfer to a higher level of care